Dgcr8 knockout embryonic stem (ES) cells lack microprocessor activity and hence all canonical microRNAs (miRNAs). These cells proliferate slowly and accumulate in G1 phase of the cell cycle 1 . Here, by screening a comprehensive library of individual miRNAs in the background of the Dgcr8 knockout ES cells, we report that multiple ES cell-specific miRNAs, members of the miR-290 family, rescue the ES cell proliferation defect. Furthermore, rescued cells no longer accumulate in the G1 phase of the cell cycle. These miRNAs function by suppressing several key regulators of the G1-S transition. These results show that post-transcriptional regulation by miRNAs promotes the G1-S transition of the ES cell cycle, enabling rapid proliferation of these cells. Our screening strategy provides an alternative and powerful approach for uncovering the role of individual miRNAs in biological processes, as it overcomes the common problem of redundancy and saturation in the miRNA system.
Dgcr8 knockout embryonic stem (ES) cells lack microprocessor activity and hence all canonical microRNAs (miRNAs). These cells proliferate slowly and accumulate in G1 phase of the cell cycle 1 . Here, by screening a comprehensive library of individual miRNAs in the background of the Dgcr8 knockout ES cells, we report that multiple ES cell-specific miRNAs, members of the miR-290 family, rescue the ES cell proliferation defect. Furthermore, rescued cells no longer accumulate in the G1 phase of the cell cycle. These miRNAs function by suppressing several key regulators of the G1-S transition. These results show that post-transcriptional regulation by miRNAs promotes the G1-S transition of the ES cell cycle, enabling rapid proliferation of these cells. Our screening strategy provides an alternative and powerful approach for uncovering the role of individual miRNAs in biological processes, as it overcomes the common problem of redundancy and saturation in the miRNA system.
ES cells are derived from the inner cell mass of the blastocyst and have been used successfully as a tool to understand molecular mechanisms of early mammalian development 2 . Because ES cells can undergo infinite and rapid self-renewal without compromising pluripotency, they hold great potential for regenerative medicine. However, rapid proliferation could be detrimental if it leads to uncontrolled cell growth following transplantation into the host. The rapid proliferation of ES cells is thought to be due to their unique cell cycle structure, especially their shortened G1 phase 3, 4 . Insights into the cell cycle control of ES cells have been gained by investigating the expression of cell cycle proteins [5] [6] [7] [8] . Furthermore, small RNAs have been implicated in ES cell proliferation on the basis of the phenotype of Dicer1 knockout ES cells 9, 10 . More recently, using a Dgcr8 knockout model, we reported a proliferation defect in ES cells specifically deficient in a subclass of small RNAs, the canonical miRNAs 1 . These miRNAdeficient cells showed a relative increase in the number of cells in the G1 phase of the cell cycle. This finding suggests that miRNAs normally suppress inhibitors of the G1-S transition, allowing the rapid transition from mitosis to S phase. However, confirmation of this hypothesis requires the identification of the specific miRNAs and targets involved in the process. Identification of individual miRNA function is complicated by the fact that miRNAs often function redundantly and exist at saturating levels in a wild-type background. To overcome this difficulty, we designed a screening strategy where individual miRNA mimics were reintroduced into an otherwise miRNA-deficient background (Dgcr8 knockout ES cells) and then evaluated for rescue of the proliferation and cell cycle defects ( Fig. 1a) .
To evaluate the efficiency at which miRNA mimics could be transfected and function in Dgcr8 knockout ES cells, we used a pool of five different siRNAs to knock down ubiquitous enhanced green fluorescent protein (eGFP) expression in the Dgcr8 null background. The transfected siRNAs were able to knock down eGFP in greater than 80% of the ES cells as shown by flow cytometry ( Supplementary  Fig. 1a online). This finding indicates high transfection and loading efficiency of small RNAs into the RNA-induced silencing complex (RISC) in the Dgcr8 knockout ES cells. These siRNAs suppressed cell growth when transfected into Dgcr8 knockout versus wild-type ES cells, even when each siRNA was introduced individually (Supplementary Fig. 1a,b ). This detrimental growth effect may be due to enhanced off-target effects of small RNAs in an otherwise global miRNA-deficient background. Transfection of the miRNA, miR-1, did not suppress growth in the Dgcr8 knockout cells but was able to repress a miR-1 reporter ( Supplementary Fig. 1c,d ). Therefore, growth suppression is sequence dependent. An initial small-scale screen using miRNA mimics showed that some miRNAs could actually promote growth of the Dgcr8 knockout ES cells, partially rescuing the proliferation defect in these cells (data not shown). Therefore, we expanded our screen to a library of 266 known mouse miRNAs ( Fig. 1b) . Fourteen of these miRNAs markedly improved Dgcr8 knockout ES cell proliferation with a Z score 43 (P value o0.001; Fig. 1c and Supplementary Table 1 online). Of note, 11 of these miRNAs shared a similar seed sequence ( Fig. 1d ), suggesting that they may regulate common targets. These data showed that our screening approach could identify miRNAs and even a common seed sequence that can promote cell proliferation.
To verify the proliferation-promoting function of these miRNAs, we resynthesized and retested the miRNA mimics in Dgcr8 knockout ES cells. MiR-33 was not retested, as it is not expressed in ES cells 11 . We verified that all except one miRNA (miR-223) rescued proliferation in the knockout background ( Fig. 2a) . Combinations of the miRNAs did not further enhance proliferation ( Supplementary Fig. 2 online) . Notably, transfection of the miRNAs into wild-type ES cells had no effect on proliferation, suggesting that they already exist at saturating levels in these cells ( Supplementary Fig. 3a online) . Furthermore, when inhibitors to these miRNAs were introduced individually or in combination, they minimally decreased proliferation in the wild-type background, suggesting that this large family of miRNAs is functionally redundant ( Supplementary Fig. 3b ). We also tested miR-294 and miR-295 in the Dicer1 knockout ES cell background, and found results similar to those for Dgcr8 knockout cells ( Supplementary Fig. 4 online). In summary, our screening approach identified multiple miRNAs that promote ES cell proliferation. These miRNAs share a similar seed sequence, act redundantly and together exist at saturating levels in this functional role.
Previous reports have shown that four of the verified miRNAs (miR-291a-3p, miR-291b-3p, miR-294 and miR-295) are highly expressed in undifferentiated mouse ES cells and rapidly downregulated upon differentiation [11] [12] [13] [14] . Indeed, the mir-290 cluster consists of the most highly expressed miRNAs in mouse ES cells 15 . Therefore, we chose to focus further analysis on these four miRNA plus mir-302, which is highly expressed in human ES cells 14 . We evaluated the effect of these miRNAs on the cell cycle on the basis of our previous finding that Dgcr8 knockout ES cells accumulate in the G1 phase of the cell cycle. All five miRNAs were able to reduce the fraction of cells in G1 with a concomitant increase in the fraction of cells in S or G2-M phase (Fig. 2b) . The most marked effects were seen for miR-291a-3p, miR-294 and miR-295, where the fraction of cells in G1 phase was similar to that in wild-type ES cells. These data show that ES cell-specific miRNAs promote ES cell proliferation, at least in part by promoting the transition of cells from G1 to S phase. Therefore, for simplicity, we call these miRNAs ESCC miRNAs, for ES cell-specific cell cycle-regulating miRNAs.
The G1-S transition in somatic cells is regulated by two cyclin-Cdk complexes: cyclin D-Cdk4,6 and cyclin E-Cdk2 (refs. 16, 17) . In mouse ES cells, the cyclin D-Cdk4,6 complex is not present, whereas the cyclin E-Cdk2 complex is present and constitutively active 4,18 . Dgcr8 MiRNAs function as repressors of translation by binding the 3¢ UTR of their target mRNAs [19] [20] [21] . Therefore, we hypothesized that the ESCC miRNAs function by suppressing an inhibitor of the cyclinE-Cdk2 complex. Cdkn1a (also known as p21, encoding P21) and Cdkn1b (p27) are inhibitors of the cyclin E-Cdk2 complex 17 . Furthermore, Cdkn1a has been reported to be post-transcriptionally regulated during ES cell differentiation 5 and the computational program Targetscan 22 identifies Cdkn1a as a potential target for all five of the ESCC miRNAs. Therefore, we set out to determine whether Cdkn1a is a true target of the ESCC miRNAs. First, we evaluated whether Cdkn1a is upregulated in the Dgcr8 knockout cells. Indeed, both mRNA and protein levels were markedly increased ( Fig. 3) . Next, we reintroduced the ESCC miRNAs into Dgcr8 knockout ES cells and evaluated their effects on Cdkn1a levels. Notably, although mRNA levels showed a variable response to the ESCC miRNAs ranging from decreased to even elevated levels, the P21 protein was consistently and substantially downregulated, confirming that these miRNAs have a predominantly post-transcriptional role ( Fig. 3) . miR-294 and miR-295 showed the most notable effects (approximately threefold downregulation). These findings are consistent with the miRNA regulation of P21 translation. It remains plausible that Cdkn1a is an indirect target of the miRNAs or that its upregulation is simply a consequence of the increased number of cells in G1. To determine whether Cdkn1a is a direct target of the ESCC miRNAs, we constructed a luciferase reporter containing the 3¢ UTR of Cdkn1a cloned downstream of a constitutively expressed firefly luciferase (Fig. 4a) . Luciferase activity was inhibited by about three-fold in wild-type ES cells compared to Dgcr8 knockout ES cells, consistent with the fold reduction of endogenous P21 protein expression (Fig. 4b) . Targetscan 4.0 predicts that two sites in the 3¢ UTR of Cdkn1a are bound by the ESCC miRNAs (Fig. 4a) . Luciferase activity increased in wild-type cells when either of these two sites was mutated (Fig. 4b) . The effect was further enhanced when both sites were mutated, suggesting that these sites act independently (1.6-and 1.4-fold increase individually and 2.3-fold increase together). However, mutation of both sites did not increase luciferase levels in wild-type ES cells to that seen in Dgcr8 knockout cells ( Fig. 4b) ,
suggesting that there are other potential miRNA target sites in the 3¢ UTR. Consistent with this hypothesis, closer evaluation of the 3¢ UTR revealed other sites partially complementary to the seed sequence of ESCC miRNAs ( Supplementary Fig. 5 online) . To confirm that regulation of the Cdkn1a 3¢ UTR is due to the ESCC miRNAs, we co-transfected individual ESCC miRNAs with the luciferase reporter. All ESCC miRNAs inhibited luciferase expression, whereas the mock transfection and co-transfection with miR-1 did not (Fig. 4c) . Furthermore, mutation of either site diminished repression, although not to control levels, again consistent with additional target sites for these miRNAs in the 3¢ UTR (Fig. 4d) . These findings show that the ESCC miRNAs directly target the 3¢ UTR of the cell cycle inhibitor Cdkn1a.
To determine the functional role of Cdkn1a in the cell cycle phenotype, we carried out knockdown and overexpression experiments in Dgcr8 knockout and wild-type cells, respectively. Four different siRNA sequences against Cdkn1a were tested, but all had toxic effects in the Dgcr8 knockout background similar to those found with GFP siRNAs ( Supplementary Fig. 1 and data not shown) . Again, this may be due to enhanced off-target effects in the knockout background. We achieved overexpression of Cdkn1a in wild-type ES cells using an EF1a promoter driving the Cdkn1a ORF linked to an internal ribosome entry site (IRES)-puromycin-resistance cassette. Stable transfection of this overexpression construct led to p21 protein levels six-to nine-fold greater than wild-type levels ( Supplementary  Fig. 6a online) . Throughout this range of overexpression, the cells consistently showed an increased G1 fraction very similar to that seen in Dgcr8 knockout cells (Fig. 4e) . These results are consistent with Cdkn1a being an important functional target of the ESCC miRNAs.
Individual miRNAs are believed to target multiple downstream mRNAs rather than follow a simple linear pathway 23 . To determine whether other G1-S regulators may be suppressed by miRNAs in ES cells, we carried out mRNA microarray analysis on wild-type and Dgcr8 knockout cells. Fewer than 2% of the total mRNAs were upregulated more than twofold in the knockout cells (data not shown). However, the expression of five members of the cyclin E-CDK2 regulatory pathway (Cdkn1a, Rb1, Rbl1, Rbl2, Lats2) was increased in the knockout cells (Fig. 5a ). All five are inhibitors of this pathway 16, 17, 24 . We confirmed increased expression of these genes by qRT-PCR (Fig. 5b) . Furthermore, Targetscan predicts target sites of the ESCC miRNAs in the 3¢ UTRs of all five inhibitors (Fig. 5c) . In contrast, one inhibitor of the cyclin E-Cdk2 pathway, Cdkn1b (also known as p27), was not upregulated in the knockout cells and is not predicted to be a target of the ESCC miRNAs. We confirmed miRNAbased inhibition of the 3¢ UTRs of Rbl2 and Lats2 with luciferasereporter assays (Fig. 5c ). Inhibition of these 3¢ UTRs was phenocopied by the introduction of miR-294 into Dgcr8 knockout cells (Supplementary Fig. 6b ). Together, these data suggest that the ESCC miRNAs act at multiple levels of the cyclin E-Cdk2 pathway to promote the transition of ES cells from G1 to S phase (Fig. 5d) .
Our results show that ES cell-specific miRNAs have a central role in expediting the G1-S transition and promoting cellular proliferation. A shortened cell cycle is critical during early mammalian embryogenesis, enabling the young embryo to rapidly grow before somatic differentiation. In contrast, an inappropriately shortened cell cycle in more differentiated cells would likely result in abnormal cell growth with associated tumor formation 25, 26 . Therefore, unraveling the miRNAbased mechanisms that promote the G1-S transition in mammalian embryonic cells is critical to understanding both normal embryonic development and cancer. We have previously shown that Dgcr8 is required for ES cell differentiation as well as normal proliferation 1 . An interesting possibility is that these two phenotypes are linked. However, the ESCC miRNAs do not rescue the differentiation defects (C. Melton and R.B., unpublished data), suggesting different miRNAs underlie the two phenotypes. The degree of redundancy we find for miRNA regulation both in terms of the number of miRNAs as well as the number of targets within the cyclin E-Cdk2 pathway is impressive, emphasizing the importance of hastening the G1-S transition in early embryonic cells. Furthermore, two recent studies have shown that the ESCC miRNAs also regulate de novo methylation by targeting Rbl2 (refs. 27,28) , indicating multiple functions of these miRNAs. Our study presents a novel screening approach that overcomes issues of redundancy and saturation that are inherent to the miRNA system; therefore, it can be generally used to evaluate multiple functions of miRNAs in a wide array of biological processes.
METHODS
Tissue culture, transfection and miRNA screening. We cultured ES cells as previously described 1 . For the miRNA screening, Dgcr8 knockout (Dgcr8 D/D ) ES cells were plated at 4,000 cells per well in a 96-well plate and grown for B24 h before transfection. We transfected small RNAs using DharmaFECT 1 (Dharmacon, Thermo Fisher) according to the manufacturer's protocol. Mouse miRIDIAN miRNA Mimic Library (Dharmacon, Thermo Fisher) was used for the screening. The final concentration of small RNAs was 100 nM unless specified. Twenty-four hours after transfection, we replaced media with fresh ES cell media. Cells were grown for another three days with media changes each day before the MTT ((4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay. The MTT assay was done as previously described 1 . We calculated Z scores using the robust Z-score analysis. We used the equation (X -median)/ MAD, where 'X' is the growth rate for cells transfected with individual miRNAs, 'median' is the median of the growth rate of all transfected cells and 'MAD' is the median absolute deviation. We obtained similar results at 10 nM concentrations of the miRNA mimics, although the proliferation-promoting effect of some miRNAs was slightly reduced (data not shown). Furthermore, the dose curve for miR-294 shows that as little as 1.25 nM still has substantial proliferation-promoting effects ( Supplementary Fig. 2b) . For experiments shown in Supplementary Figure 3 , the MTT assay was done as described above except 2,000 wild-type ES cells per well were plated in a 96-well plate. We plated wild-type ES cells at half the number of Dgcr8 knockout cells on day 0 so that roughly equal numbers of cells were present on the day of transfection (day 1). This was also necessary to ensure that wild-type ES cells were not overly confluent at the time of the MTT assay.
Cell cycle, quantitative real-time PCR and Affymetrix arrays. For the cell cycle and quantitative PCR analysis, 50,000 Dgcr8 D/D ES cells or 25,000 wildtype ES cells per well were plated in a 12-well plate and grown for B24 h before transfection. We split each well of cells into 2 wells of a 12-well plate 24 h after transfection with synthetic miRNA mimics. After growing for another 24 h, one well of cells was collected for cell cycle analysis, and the other well of cells was used for RNA extraction. We carried out cell cycle analysis and quantitative real-time PCR for mRNAs as previously described 1 . Sequences of quantitative PCR primers are listed in Supplementary Table 2 online. Affymetrix Mouse Gene 1.0 ST arrays were probed by the Gladstone Genomics Core (see URLs section below). We assayed three biological samples for each cell line and analyzed data using Affymetrix Expression Console software. We used the robust multichip analysis (RMA) algorithm to normalize the array signal data across chips.
Immunoblot analysis. We plated 0.3 million Dgcr8 D/D ES cells or 0.15 million wild-type ES cells per well in a 6-well plate and let them grow for B24 h before transfection. Proteins were extracted using EBC buffer (50 mM Tris-HCl, pH 8.0, 120 mM NaCl, 0.5% Nonidet P-40, 1 mM EDTA) containing 1Â protease inhibitor cocktail (Roche) 24 h post transfection. We resolved around one-third of the total cell lysate on a 12% SDS-PAGE. The proteins were then transferred to a PVDF membrane (Biorad) and processed for immunodetection. We analyzed blots using ImageJ software.
Luciferase reporter constructs. To construct the luciferase reporter with wildtype Cdkn1a 3¢ UTR, we cloned the 3¢ UTR of Cdkn1a by PCR from the cDNA of reverse-transcribed wild-type ES cell mRNA. PCR products were subcloned to pCR2.1-Topo vector (Invitrogen) and sequenced. The 3¢ UTR was then cloned into the XbaI site of pGL3-control vector (Promega). To construct luciferase reporters with mutations, we first did PCR using two sets of primers to generate two fragments of 3¢ UTR overlapping at mutation sites. These two fragments were then annealed and used as templates to amplify mutated 3¢ UTR. We then processed PCR products with mutations as above to make mutant luciferase reporters. The reporters for 3¢ UTRs of other mRNAs were constructed using a similar approach as above. Sequences of primers are listed in Supplementary Table 2 .
Luciferase reporter assay. We plated 16,000 Dgcr8 D/D ES cells or 8,000 wildtype ES cells per well in a 96-well plate and let them grow for at least 16 h before transfection. For the transfection experiments, we transfected a mixture of 160 ng of reporter and 40 ng of control vector pRL-TK (Promega) to each well using 1 ml Fugene-6 (Roche). Cells were lysed 12-16 h later and processed for luciferase assay using Dual-Luciferase Reporter Assay System (Promega). We measured luciferase activity by Mithras LB 940 (Berthold Technologies). For the co-transfection with miRNAs, we transfected miRNAs using Dharmafect (Dharmacon, Thermo Fisher) B10 h before transfecting the luciferase reporters.
Overexpression of Cdkn1a. We plated 0.5 million cells in one well of a 6-well plate B24 h before transfection. Cells were transfected with 5 mg plasmids. Cdkn1a or GFP was under control of E2F1a promoter and upstream of IRES-Pac (puromycin resistance). Cells were then selected at 0.6 mg/ml puromycin for at least 12 days before cell cycle and protein analysis. After selection, the fraction of GFP-positive cells is typically more than 95%. To prepare samples for cell cycle and protein analysis, 0.5 million cells were plated in one well of a 6-well plate and grown for B24 h.
URLs. Gladstone Genomics Core, http://www.gladstone.ucsf.edu/gladstone/ php/?sitename¼genomicscore#.
Note: Supplementary information is available on the Nature Genetics website.
